| CXHB2400043 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | Supplementary Application | 2024-02-19 | | Peg BIO Co Ltd | | | view |
| CXHS2300088 | 维派那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2023-09-26 | | | | | view |
| JYHZ2300037 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | License Renew | 2023-01-19 | | | | | view |
| JYHZ2300036 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | License Renew | 2023-01-19 | | | | | view |
| JYHB2200688 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | | | | view |
| JYHB2200687 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2022-12-31 | | | | | view |
| CYHS2200468 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-03-21 | | Hybio Pharmaceutical Co Ltd | | | view |
| CYHS2200469 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-03-21 | | Hybio Pharmaceutical Co Ltd | | | view |
| CYHS2200215 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs(4) | Generic Drug | 2022-01-28 | | Chengdu Shengnuo Biopharm Co Ltd | | | view |
| JTH2100669 | 艾塞那肽 | exenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2021-10-11 | | | | | view |
| CXHL2101223 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-06-25 | | Peg BIO Co Ltd | | | view |
| JYHB2101083 | 注射用艾塞那肽微球 | exenatide | Lyophilized | Chemical Drugs | Supplementary Application | 2021-05-10 | | | | | view |
| CXHL2100209 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs(1) | New Drug Application | 2021-03-27 | 派格生物医药（苏州）股份有限公司 | Peg BIO Co Ltd | In Review | 2021-03-26 | view |
| JTH2000345 | 艾塞那肽 | exenatide | Active ingredient | Chemical Drugs | Disposable Import Drug Application | 2020-12-01 | Bachem Americas, Inc. | Bachem Americas Inc | Certificate Issued | 2020-12-23 | view |
| JYHB2002071 | 注射用艾塞那肽微球 | exenatide | Lyophilized | Chemical Drugs | Supplementary Application | 2020-10-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-11-12 | view |
| JYHB2001879 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-09-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-11-12 | view |
| JYHB2001878 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-09-25 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2020-11-12 | view |
| JYHB2001204 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-07-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-08-17 | view |
| JYHB2001203 | 艾塞那肽注射液 | exenatide | Injection | Chemical Drugs | Supplementary Application | 2020-07-30 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Filed | 2020-08-17 | view |
| CXHB2000061 | 聚乙二醇化艾塞那肽注射液 | PB-119 | Injection | Chemical Drugs | Supplementary Application | 2020-06-29 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | In Review | 2020-06-28 | view |
